{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:33Z","timestamp":1786982193936,"version":"build-2736575974"},"reference-count":217,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12026-025-09653-2","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T03:53:44Z","timestamp":1750132424000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Statins and adhesion molecules: a review of a novel pleiotropic property of statins"],"prefix":"10.1007","volume":"73","author":[{"given":"Mahvash","family":"Sadeghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Dehnavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz Keshavarz","family":"Shahbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadijeh","family":"Koushki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra E.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tannaz","family":"Jamialahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"issue":"12","key":"9653_CR1","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.3390\/molecules25122835","volume":"25","author":"I Tvaro\u0161ka","year":"2020","unstructured":"Tvaro\u0161ka I, Selvaraj C, Ko\u010da J. Selectins\u2014the two Dr. Jekyll and Mr. Hyde faces of adhesion molecules\u2014a review. Molecules. 2020;25(12):2835.","journal-title":"Molecules"},{"key":"9653_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00147","volume":"5","author":"KA Mosevoll","year":"2018","unstructured":"Mosevoll KA, Johansen S, Wendelbo \u00d8, Nepstad I, Bruserud \u00d8, Reikvam H. Cytokines, adhesion molecules, and matrix metalloproteases as predisposing, diagnostic, and prognostic factors in venous thrombosis. Front Med. 2018;5: 147.","journal-title":"Front Med"},{"key":"9653_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01078","volume":"10","author":"H Harjunp\u00e4\u00e4","year":"2019","unstructured":"Harjunp\u00e4\u00e4 H, Llort Asens M, Guenther C, Fagerholm SC. Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment. Front Immunol. 2019;10: 1078.","journal-title":"Front Immunol"},{"issue":"5","key":"9653_CR4","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1253\/circj.CJ-10-0110","volume":"74","author":"Q Zhou","year":"2010","unstructured":"Zhou Q, Liao JK. Pleiotropic effects of statins\u2013basic research and clinical perspectives\u2013. Circ J. 2010;74(5):818\u201326.","journal-title":"Circ J"},{"key":"9653_CR5","doi-asserted-by":"crossref","unstructured":"Dehnavi S, Kiani A, Sadeghi M, Biregani AF, Banach M, Atkin SL, et al. Targeting AMPK by statins: a potential therapeutic approach. Drugs. 2021;81(8):923\u201333.","DOI":"10.1007\/s40265-021-01510-4"},{"issue":"2","key":"9653_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12016-020-08791-9","volume":"60","author":"K Koushki","year":"2021","unstructured":"Koushki K, Shahbaz SK, Mashayekhi K, Sadeghi M, Zayeri ZD, Taba MY, et al. Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and toll-like receptor pathways. Clin Rev Allergy Immunol. 2021;60(2):175\u201399.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7","key":"9653_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00210-016-1252-4","volume":"389","author":"O Bedi","year":"2016","unstructured":"Bedi O, Dhawan V, Sharma P, Kumar P. Pleiotropic effects of statins: new therapeutic targets in drug design. Naunyn Schmiedebergs Arch Pharmacol. 2016;389(7):695\u2013712.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"9653_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2024.111045","volume":"216","author":"J Liao","year":"2024","unstructured":"Liao J, Duan Y, Liu Y, Chen H, An Z, Chen Y, et al. Simvastatin alleviates glymphatic system damage via the VEGF-C\/VEGFR3\/PI3K-Akt pathway after experimental intracerebral hemorrhage. Brain Res Bull. 2024;216: 111045.","journal-title":"Brain Res Bull"},{"key":"9653_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107614","volume":"214","author":"S Dehnavi","year":"2020","unstructured":"Dehnavi S, Sohrabi N, Sadeghi M, Lansberg P, Banach M, Al-Rasadi K, et al. Statins and autoimmunity: state-of-the-art. Pharmacol Ther. 2020;214: 107614.","journal-title":"Pharmacol Ther"},{"key":"9653_CR10","doi-asserted-by":"publisher","first-page":"8732360","DOI":"10.1155\/2022\/8732360","volume":"2022","author":"T Kandelouei","year":"2022","unstructured":"Kandelouei T, Abbasifard M, Imani D, Aslani S, Razi B, Fasihi M, et al. Effect of statins on serum level of hs-CRP and CRP in patients with cardiovascular diseases: a systematic review and meta-analysis of randomized controlled trials. Mediators Inflamm. 2022;2022:8732360.","journal-title":"Mediators Inflamm"},{"issue":"6","key":"9653_CR11","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/89058","volume":"7","author":"G Weitz-Schmidt","year":"2001","unstructured":"Weitz-Schmidt G, Welzenbach K, Brinkmann V, Kamata T, Kallen J, Bruns C, et al. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med. 2001;7(6):687\u201392.","journal-title":"Nat Med"},{"issue":"8","key":"9653_CR12","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1134\/S0006297918080023","volume":"83","author":"T Arefieva","year":"2018","unstructured":"Arefieva T, Filatova AY, Potekhina A, Shchinova A. Immunotropic effects and proposed mechanism of action for 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors (statins). Biochem Mosc. 2018;83(8):874\u201389.","journal-title":"Biochem Mosc"},{"issue":"22","key":"9653_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228745","volume":"21","author":"C Murphy","year":"2020","unstructured":"Murphy C, Deplazes E, Cranfield CG, Garcia A. The role of structure and biophysical properties in the pleiotropic effects of statins. Int J Mol Sci. 2020;21(22): 8745.","journal-title":"Int J Mol Sci"},{"issue":"5519","key":"9653_CR14","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.1059344","volume":"292","author":"ES Istvan","year":"2001","unstructured":"Istvan ES, Deisenhofer J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science. 2001;292(5519):1160\u20134.","journal-title":"Science"},{"issue":"7","key":"9653_CR15","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1128\/AEM.02820-06","volume":"73","author":"X Xie","year":"2007","unstructured":"Xie X, Tang Y. Efficient synthesis of simvastatin by use of whole-cell biocatalysis. Appl Environ Microbiol. 2007;73(7):2054\u201360.","journal-title":"Appl Environ Microbiol"},{"issue":"4","key":"9653_CR16","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00253-009-2239-6","volume":"85","author":"J Barrios-Gonz\u00e1lez","year":"2010","unstructured":"Barrios-Gonz\u00e1lez J, Miranda RU. Biotechnological production and applications of statins. Appl Microbiol Biotechnol. 2010;85(4):869\u201383.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"9653_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1124\/pr.111.004994","volume":"64","author":"P Gazzerro","year":"2012","unstructured":"Gazzerro P, Proto MC, Gangemi G, Malfitano AM, Ciaglia E, Pisanti S, et al. Pharmacological actions of statins: a critical appraisal in the management of cancer. Pharmacol Rev. 2012;64(1):102\u201346.","journal-title":"Pharmacol Rev"},{"key":"9653_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104469","volume":"149","author":"SK Shahbaz","year":"2019","unstructured":"Shahbaz SK, Sadeghi M, Koushki K, Penson PE, Sahebkar A. Regulatory T cells: possible mediators for the anti-inflammatory action of statins. Pharmacol Res. 2019;149: 104469.","journal-title":"Pharmacol Res"},{"key":"9653_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172704","volume":"863","author":"N Mohammadkhani","year":"2019","unstructured":"Mohammadkhani N, Gharbi S, Rajani HF, Farzaneh A, Mahjoob G, Hoseinsalari A, et al. Statins: complex outcomes but increasingly helpful treatment options for patients. Eur J Pharmacol. 2019;863: 172704.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"9653_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jcsm.12654","volume":"12","author":"H Mollazadeh","year":"2021","unstructured":"Mollazadeh H, Tavana E, Fanni G, Bo S, Banach M, Pirro M, et al. Effects of statins on mitochondrial pathways. J Cachexia Sarcopenia Muscle. 2021;12(2):237\u201351.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"9653_CR21","first-page":"546","volume":"114","author":"A Sahebkar","year":"2015","unstructured":"Sahebkar A, Serban C, Mikhailidis DP, Undas A, Lip GYH, Muntner P, et al. Association between statin use and plasma d-dimer levels: a systematic review and meta-analysis of randomised controlled trials. Thromb Haemost. 2015;114(3):546\u201357.","journal-title":"Thromb Haemost"},{"key":"9653_CR22","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.atherosclerosis.2016.07.897","volume":"253","author":"P Chru\u015bciel","year":"2016","unstructured":"Chru\u015bciel P, Sahebkar A, Rembek-Wieliczko M, Serban MC, Ursoniu S, Mikhailidis DP, et al. Impact of statin therapy on plasma adiponectin concentrations: a systematic review and meta-analysis of 43 randomized controlled trial arms. Atherosclerosis. 2016;253:194\u2013208.","journal-title":"Atherosclerosis"},{"key":"9653_CR23","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.metabol.2023.155659","volume":"146","author":"A Sahebkar","year":"2023","unstructured":"Sahebkar A, Foroutan Z, Katsiki N, Jamialahmadi T, Mantzoros CS. Ferroptosis, a new pathogenetic mechanism in cardiometabolic diseases and cancer: is there a role for statin therapy? Metabolism: Clin Exp. 2023;146:146.","journal-title":"Metabolism: Clin Exp"},{"issue":"3","key":"9653_CR24","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1160\/th15-08-0620","volume":"115","author":"A Sahebkar","year":"2016","unstructured":"Sahebkar A, Serban C, Ursoniu S, Mikhailidis DP, Undas A, Lip GYH, et al. The impact of statin therapy on plasma levels of von Willebrand factor antigen: systematic review and meta-analysis of randomised placebo-controlled trials. Thromb Haemost. 2016;115(3):520\u201332.","journal-title":"Thromb Haemost"},{"issue":"23_suppl_1","key":"9653_CR25","doi-asserted-by":"publisher","first-page":"III-39","DOI":"10.1161\/01.CIR.0000131517.20177.5a","volume":"109","author":"J Davignon","year":"2004","unstructured":"Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation. 2004;109(23_suppl_1):III-39\u2013III\u221243.","journal-title":"Circulation"},{"key":"9653_CR26","doi-asserted-by":"crossref","unstructured":"Bland AR, Payne FM, Ashton JC, Jamialahmadi T, Sahebkar A. The cardioprotective actions of statins in targeting mitochondrial dysfunction associated with myocardial ischaemia-reperfusion injury. Pharmacol Res. 2022;175:105986.","DOI":"10.1016\/j.phrs.2021.105986"},{"issue":"1","key":"9653_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.plipres.2014.07.002","volume":"56","author":"A Sahebkar","year":"2014","unstructured":"Sahebkar A, Chew GT, Watts GF. Recent advances in pharmacotherapy for hypertriglyceridemia. Prog Lipid Res. 2014;56(1):47\u201366.","journal-title":"Prog Lipid Res"},{"key":"9653_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/srep09902","volume":"5","author":"C Serban","year":"2015","unstructured":"Serban C, Sahebkar A, Ursoniu S, Mikhailidis DP, Rizzo M, Lip GYH, et al. A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations. Sci Rep. 2015;5:5.","journal-title":"Sci Rep"},{"issue":"12","key":"9653_CR29","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nrd1901","volume":"4","author":"MK Jain","year":"2005","unstructured":"Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov. 2005;4(12):977\u201387.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"9653_CR30","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/01.CIR.0000080895.05158.8B","volume":"108","author":"MH Shishehbor","year":"2003","unstructured":"Shishehbor MH, Brennan M-L, Aviles RJ, Fu X, Penn MS, Sprecher DL, et al. Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation. 2003;108(4):426\u201331.","journal-title":"Circulation"},{"key":"9653_CR31","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.phrs.2018.08.014","volume":"135","author":"A Bahrami","year":"2018","unstructured":"Bahrami A, Parsamanesh N, Atkin SL, Banach M, Sahebkar A. Effect of statins on toll-like receptors: a new insight to pleiotropic effects. Pharmacol Res. 2018;135:230\u20138.","journal-title":"Pharmacol Res"},{"issue":"4","key":"9653_CR32","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11745-010-3517-x","volume":"46","author":"SMR Parizadeh","year":"2011","unstructured":"Parizadeh SMR, Azarpazhooh MR, Moohebati M, Nematy M, Ghayour-Mobarhan M, Tavallaie S, et al. Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial. Lipids. 2011;46(4):333\u201340.","journal-title":"Lipids"},{"issue":"1","key":"9653_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1465-9921-12-113","volume":"12","author":"D Schaafsma","year":"2011","unstructured":"Schaafsma D, McNeill KD, Mutawe MM, Ghavami S, Unruh H, Jacques E, et al. Simvastatin inhibits TGF\u03b21-induced fibronectin in human airway fibroblasts. Respir Res. 2011;12(1):1\u201310.","journal-title":"Respir Res"},{"key":"9653_CR34","doi-asserted-by":"publisher","unstructured":"Vahedian-Azimi A, Mannarino MR, Shojaie S, Rahimibashar F, Galeh HEG, Banach M, et al. The effect of statins on prevalence and mortality of influenza virus infection: a systematic review and meta-analysis. Arch Med Sci. 2022;18(6).https:\/\/doi.org\/10.5114\/aoms\/149633","DOI":"10.5114\/aoms\/149633"},{"key":"9653_CR35","doi-asserted-by":"publisher","unstructured":"Vahedian-Azimi A, Mohammadi SM, Banach M, Beni FH, Guest PC, Al-Rasadi K, et al. Improved COVID-19 outcomes following statin therapy: an updated systematic review and meta-analysis. BioMed Res Int. 2021.https:\/\/doi.org\/10.1155\/2021\/1901772","DOI":"10.1155\/2021\/1901772"},{"key":"9653_CR36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.pnpbp.2015.11.013","volume":"66","author":"Q Ling","year":"2016","unstructured":"Ling Q, Tejada-Simon M. Statins and the brain: new perspective for old drugs. Prog Neuropsychopharmacol Biol Psychiatry. 2016;66:80\u20136.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"9653_CR37","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.1111\/j.1559-4572.2008.00052.x","volume":"4","author":"MS Kostapanos","year":"2009","unstructured":"Kostapanos MS, Liberopoulos EN, Elisaf MS. Statin pleiotropy against renal injury. J Cardiometab Syndr. 2009;4(1):E4\u20139.","journal-title":"J Cardiometab Syndr"},{"issue":"4","key":"9653_CR38","first-page":"952","volume":"19","author":"A Vahedian-Azimi","year":"2023","unstructured":"Vahedian-Azimi A, Beni FH, Fras Z, Banach M, Mohammadi SM, Jamialahmadi T, et al. Effects of statins on the incidence and outcomes of acute kidney injury in critically ill patients: a systematic review and meta-analysis. Arch Med Sci. 2023;19(4):952\u201364.","journal-title":"Arch Med Sci"},{"key":"9653_CR39","unstructured":"Bhatta A. Comparison of CD28 and ICAM-1 signal transduction pathways, earliest signaling events involving CD45 and effect of statins and low pH on T cell function. University of Kansas; 2020. Available at: https:\/\/kuscholarworks.ku.edu\/entities\/publication\/f464f04c-42af-4543-a7df-1a52021b0032."},{"issue":"12","key":"9653_CR40","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","volume":"97","author":"U Laufs","year":"1998","unstructured":"Laufs U, La Fata V, Plutzky J, Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation. 1998;97(12):1129\u201335.","journal-title":"Circulation"},{"issue":"50","key":"9653_CR41","doi-asserted-by":"publisher","first-page":"31725","DOI":"10.1074\/jbc.272.50.31725","volume":"272","author":"U Laufs","year":"1997","unstructured":"Laufs U, La Fata V, Liao JK. Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase. J Biol Chem. 1997;272(50):31725\u20139.","journal-title":"J Biol Chem"},{"issue":"7","key":"9653_CR42","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1161\/01.RES.83.7.683","volume":"83","author":"M Essig","year":"1998","unstructured":"Essig M, Nguyen G, Pri\u00e9 D, Escoubet B, Sraer J-D, Friedlander G. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells: role of geranylgeranylation and Rho proteins. Circ Res. 1998;83(7):683\u201390.","journal-title":"Circ Res"},{"issue":"12","key":"9653_CR43","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1172\/JCI1500","volume":"101","author":"O Hern\u00e1ndez-Perera","year":"1998","unstructured":"Hern\u00e1ndez-Perera O, P\u00e9rez-Sala D, Navarro-Antol\u00edn J, S\u00e1nchez-Pascuala R, Hern\u00e1ndez G, D\u00edaz C, et al. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Investig. 1998;101(12):2711\u20139.","journal-title":"J Clin Investig"},{"issue":"3","key":"9653_CR44","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3892\/etm.2013.1208","volume":"6","author":"L Han","year":"2013","unstructured":"Han L, Li M, Liu X. Effects of long-term atorvastatin treatment on cardiac aging. Exp Ther Med. 2013;6(3):721\u20136.","journal-title":"Exp Ther Med"},{"key":"9653_CR45","doi-asserted-by":"crossref","unstructured":"Parsamanesh N, Karami-Zarandi M, Banach M, Penson PE, Sahebkar A. Effects of statins on myocarditis: a review of underlying molecular mechanisms. Prog Cardiovasc Dis. 2021;67:53-64.","DOI":"10.1016\/j.pcad.2021.02.008"},{"issue":"12","key":"9653_CR46","doi-asserted-by":"publisher","first-page":"990","DOI":"10.18632\/aging.100213","volume":"2","author":"K Yudoh","year":"2010","unstructured":"Yudoh K, Karasawa R. Statin prevents chondrocyte aging and degeneration of articular cartilage in osteoarthritis (OA). Aging (Albany NY). 2010;2(12):990.","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"9653_CR47","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/wrr.12811","volume":"28","author":"P Xie","year":"2020","unstructured":"Xie P, Dolivo DM, Jia S, Cheng X, Salcido J, Galiano RD, et al. Liposome-encapsulated statins reduce hypertrophic scarring through topical application. Wound Repair Regen. 2020;28(4):460\u20139.","journal-title":"Wound Repair Regen"},{"key":"9653_CR48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.exger.2014.01.015","volume":"52","author":"X Gong","year":"2014","unstructured":"Gong X, Ma Y, Ruan Y, Fu G, Wu S. Long-term atorvastatin improves age-related endothelial dysfunction by ameliorating oxidative stress and normalizing eNOS\/iNOS imbalance in rat aorta. Exp Gerontol. 2014;52:9\u201317.","journal-title":"Exp Gerontol"},{"issue":"3","key":"9653_CR49","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1172\/JCI200113131","volume":"108","author":"J Llevadot","year":"2001","unstructured":"Llevadot J, Murasawa S, Kureishi Y, Uchida S, Masuda H, Kawamoto A, et al. HMG-CoA reductase inhibitor mobilizes bone marrow\u2013derived endothelial progenitor cells. J Clin Investig. 2001;108(3):399\u2013405.","journal-title":"J Clin Investig"},{"issue":"3","key":"9653_CR50","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1172\/JCI200113152","volume":"108","author":"S Dimmeler","year":"2001","unstructured":"Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase\/Akt pathway. J Clin Investig. 2001;108(3):391\u20137.","journal-title":"J Clin Investig"},{"issue":"1","key":"9653_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0735-1097(99)00525-2","volume":"35","author":"CJ Vaughan","year":"2000","unstructured":"Vaughan CJ, Gotto AM, Basson CT. The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol. 2000;35(1):1\u201310.","journal-title":"J Am Coll Cardiol"},{"key":"9653_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11883-020-00837-9","volume":"22","author":"H Kouhpeikar","year":"2020","unstructured":"Kouhpeikar H, Delbari Z, Sathyapalan T, Simental-Mend\u00eda LE, Jamialahmadi T, Sahebkar A. The effect of statins through mast cells in the pathophysiology of atherosclerosis: a review. Curr Atheroscler Rep. 2020;22:1\u20138.","journal-title":"Curr Atheroscler Rep"},{"issue":"3","key":"9653_CR53","first-page":"475","volume":"28","author":"D Peng","year":"2008","unstructured":"Peng D, Li Z. Effect of simvastatin on monocyte CX3CR1 expression in patients with acute coronary syndrome. J South Med Univ. 2008;28(3):475\u20137.","journal-title":"J South Med Univ"},{"key":"9653_CR54","unstructured":"Kuznetsova G, Potekhina A, Aref\u2019eva T, Ruleva NY, Filatova AY, Shchinova A, et al. Effect of atorvastatin on the blood T cell subset composition in patients with stable effort angina. Ateroskl Dislipidem. 2016;4:30\u20139."},{"key":"9653_CR55","doi-asserted-by":"crossref","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023.","DOI":"10.1038\/sigtrans.2017.23"},{"issue":"4","key":"9653_CR56","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/jor.22536","volume":"32","author":"CH Chang","year":"2014","unstructured":"Chang CH, Hsu YM, Chen YC, Lin FH, Sadhasivam S, Loo ST, et al. Anti-inflammatory effects of hydrophilic and lipophilic statins with hyaluronic acid against LPS-induced inflammation in porcine articular chondrocytes. J Orthop Res. 2014;32(4):557\u201365.","journal-title":"J Orthop Res"},{"issue":"1","key":"9653_CR57","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.cellimm.2012.09.008","volume":"279","author":"SS Yang","year":"2012","unstructured":"Yang SS, Li R, Qu X, Fang W, Quan Z. Atorvastatin decreases toll-like receptor 4 expression and downstream signaling in human monocytic leukemia cells. Cell Immunol. 2012;279(1):96\u2013102.","journal-title":"Cell Immunol"},{"issue":"2","key":"9653_CR58","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0735-1097(00)00771-3","volume":"36","author":"D Ferro","year":"2000","unstructured":"Ferro D, Parrotto S, Basili S, Alessandri C, Violi F. Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia. J Am Coll Cardiol. 2000;36(2):427\u201331.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"9653_CR59","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/FJC.0b013e318211703b","volume":"57","author":"R Krysiak","year":"2011","unstructured":"Krysiak R, Okopien B. The effect of ezetimibe and simvastatin on monocyte cytokine release in patients with isolated hypercholesterolemia. J Cardiovasc Pharmacol. 2011;57(4):505\u201312.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"9653_CR60","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2005.10.015","volume":"188","author":"NR Veillard","year":"2006","unstructured":"Veillard NR, Braunersreuther V, Arnaud C, Burger F, Pelli G, Steffens S, et al. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages. Atherosclerosis. 2006;188(1):51\u20138.","journal-title":"Atherosclerosis"},{"issue":"8","key":"9653_CR61","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.clinthera.2013.06.019","volume":"35","author":"A Sahebkar","year":"2013","unstructured":"Sahebkar A, Watts GF. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes. Clin Ther. 2013;35(8):1082\u201398.","journal-title":"Clin Ther"},{"issue":"6","key":"9653_CR62","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10557-013-6479-4","volume":"27","author":"A Sahebkar","year":"2013","unstructured":"Sahebkar A, Watts GF. New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect? Cardiovasc Drugs Ther. 2013;27(6):559\u201367.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"4","key":"9653_CR63","doi-asserted-by":"publisher","first-page":"517","DOI":"10.4093\/dmj.2022.0198","volume":"46","author":"K Kim","year":"2022","unstructured":"Kim K, Ginsberg HN, Choi SH. New, novel lipid-lowering agents for reducing cardiovascular risk: beyond statins. Diabetes Metab J. 2022;46(4):517\u201332.","journal-title":"Diabetes Metab J"},{"issue":"2","key":"9653_CR64","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4161\/cam.3.2.8036","volume":"3","author":"H Truong","year":"2009","unstructured":"Truong H, Danen EH. Integrin switching modulates adhesion dynamics and cell migration. Cell Adh Migr. 2009;3(2):179\u201381.","journal-title":"Cell Adh Migr"},{"key":"9653_CR65","doi-asserted-by":"crossref","unstructured":"Adu-Gyamfi EA, Czika A, Gorleku PN, Ullah A, Panhwar Z, Ruan L-L, et al. The involvement of cell adhesion molecules, tight junctions, and gap junctions in human placentation. Reprod Sci. 2020;28(2):305\u201320.","DOI":"10.1007\/s43032-020-00364-7"},{"key":"9653_CR66","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1017\/S0033583519000088","volume":"52","author":"CG Gahmberg","year":"2019","unstructured":"Gahmberg CG, Gr\u00f6nholm M, Madhavan S, Jahan F, Mikkola E, Viazmina L, et al. Regulation of cell adhesion: a collaborative effort of integrins, their ligands, cytoplasmic actors, and phosphorylation. Q Rev Biophys. 2019;52:52.","journal-title":"Q Rev Biophys"},{"issue":"1","key":"9653_CR67","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00441-009-0834-6","volume":"339","author":"M Barczyk","year":"2010","unstructured":"Barczyk M, Carracedo S, Gullberg D. Integrins. Cell Tissue Res. 2010;339(1):269\u201380.","journal-title":"Cell Tissue Res"},{"issue":"3","key":"9653_CR68","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a004994","volume":"3","author":"ID Campbell","year":"2011","unstructured":"Campbell ID, Humphries MJ. Integrin structure, activation, and interactions. Cold Spring Harb Perspect Biol. 2011;3(3): a004994.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"9653_CR69","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.biophys.31.101101.140922","volume":"31","author":"M Shimaoka","year":"2002","unstructured":"Shimaoka M, Takagi J, Springer TA. Conformational regulation of integrin structure and function. Annu Rev Biophys Biomol Struct. 2002;31(1):485\u2013516.","journal-title":"Annu Rev Biophys Biomol Struct"},{"issue":"5\u20136","key":"9653_CR70","first-page":"353","volume":"52","author":"Z Fan","year":"2015","unstructured":"Fan Z, Ley K. Leukocyte arrest: biomechanics and molecular mechanisms of \u03b22 integrin activation. Biorheology. 2015;52(5\u20136):353\u201377.","journal-title":"Biorheology"},{"issue":"12","key":"9653_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/cells8121503","volume":"8","author":"E Hintermann","year":"2019","unstructured":"Hintermann E, Christen U. The many roles of cell adhesion molecules in hepatic fibrosis. Cells. 2019;8(12): 1503.","journal-title":"Cells"},{"issue":"1","key":"9653_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-18533-1","volume":"8","author":"AHM Kamal","year":"2018","unstructured":"Kamal AHM, Chakrabarty JK, Udden SN, Zaki MH, Chowdhury SM. Inflammatory proteomic network analysis of statin-treated and lipopolysaccharide-activated macrophages. Sci Rep. 2018;8(1):1\u201313.","journal-title":"Sci Rep"},{"issue":"4","key":"9653_CR73","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3324\/haematol.2010.032912","volume":"96","author":"AA Canalli","year":"2011","unstructured":"Canalli AA, Proen\u00e7a RF, Franco-Penteado CF, Traina F, Sakamoto TM, Saad ST, et al. Participation of Mac-1, LFA-1 and VLA-4 integrins in the in vitro adhesion of sickle cell disease neutrophils to endothelial layers, and reversal of adhesion by simvastatin. Haematologica. 2011;96(4):526.","journal-title":"Haematologica"},{"issue":"5","key":"9653_CR74","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1189\/jlb.0510279","volume":"89","author":"S Zhang","year":"2011","unstructured":"Zhang S, Rahman M, Zhang S, Qi Z, Thorlacius H. Simvastatin antagonizes CD40L secretion, CXC chemokine formation, and pulmonary infiltration of neutrophils in abdominal sepsis. J Leukoc Biol. 2011;89(5):735\u201342.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"9653_CR75","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00011-012-0579-7","volume":"62","author":"AAA Silveira","year":"2013","unstructured":"Silveira AAA, Dominical VM, Lazarini M, Costa FF, Conran N. Simvastatin abrogates inflamed neutrophil adhesive properties, in association with the inhibition of Mac-1 integrin expression and modulation of Rho kinase activity. Inflamm Res. 2013;62(2):127\u201332.","journal-title":"Inflamm Res"},{"key":"9653_CR76","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.intimp.2018.03.025","volume":"58","author":"AAA Silveira","year":"2018","unstructured":"Silveira AAA, Dominical VM, Vital DM, Ferreira WA Jr, Costa FTM, Werneck CC, et al. Attenuation of TNF-induced neutrophil adhesion by simvastatin is associated with the inhibition of Rho-GTPase activity, p50 activity and morphological changes. Int Immunopharmacol. 2018;58:160\u20135.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"9653_CR77","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1189\/jlb.0608382","volume":"85","author":"B Maher","year":"2009","unstructured":"Maher B, Dhonnchu TN, Burke J, Soo A, Wood A, Watson R. Statins alter neutrophil migration by modulating cellular Rho activity\u2014a potential mechanism for statins-mediated pleotropic effects? J Leukoc Biol. 2009;85(1):186\u201393.","journal-title":"J Leukoc Biol"},{"issue":"4","key":"9653_CR78","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/1755-5922.12126","volume":"33","author":"A Cerda","year":"2015","unstructured":"Cerda A, Rodrigues AC, Alves C, Genvigir FDV, Fajardo CM, Dorea EL, et al. Modulation of adhesion molecules by cholesterol-lowering therapy in mononuclear cells from hypercholesterolemic patients. Cardiovasc Ther. 2015;33(4):168\u201376.","journal-title":"Cardiovasc Ther"},{"issue":"2","key":"9653_CR79","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s10753-016-0497-x","volume":"40","author":"CP Barbosa","year":"2017","unstructured":"Barbosa CP, Bracht L, Ames FQ, de Souza Silva-Comar FM, Tronco RP, Bersani-Amado CA. Effects of ezetimibe, simvastatin, and their combination on inflammatory parameters in a rat model of adjuvant-induced arthritis. Inflammation. 2017;40(2):717\u201324.","journal-title":"Inflammation"},{"issue":"3","key":"9653_CR80","doi-asserted-by":"publisher","first-page":"146","DOI":"10.59566\/IJBS.2014.10146","volume":"10","author":"MJ Hamblin","year":"2014","unstructured":"Hamblin MJ, Eberlein M, Black K, Hallowell R, Collins S, Chan-Li Y, et al. Lovastatin inhibits low molecular weight hyaluronan induced chemokine expression via LFA-1 and decreases bleomycin-induced pulmonary fibrosis. Int J Biomed Sci: IJBS. 2014;10(3):146.","journal-title":"Int J Biomed Sci: IJBS"},{"issue":"5","key":"9653_CR81","first-page":"616","volume":"62","author":"M Korhonen","year":"1990","unstructured":"Korhonen M, Yl\u00e4nne J, Laitinen L, Virtanen I. Distribution of beta 1 and beta 3 integrins in human fetal and adult kidney. Lab Investig; J Tech Methods pathol. 1990;62(5):616\u201325.","journal-title":"Lab Investig; J Tech Methods pathol"},{"issue":"3","key":"9653_CR82","first-page":"571","volume":"141","author":"S Adler","year":"1992","unstructured":"Adler S. Characterization of glomerular epithelial cell matrix receptors. Am J Pathol. 1992;141(3):571.","journal-title":"Am J Pathol"},{"issue":"1","key":"9653_CR83","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11010-014-2220-2","volume":"398","author":"J Liu","year":"2015","unstructured":"Liu J, Zhang B, Chai Y, Xu Y, Xing C, Wang X. Fluvastatin attenuated the effect of expression of \u03b21 integrin in PAN-treated podocytes by inhibiting reactive oxygen species. Mol Cell Biochem. 2015;398(1):207\u201315.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"9653_CR84","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/cvr\/cvv253","volume":"109","author":"T Minami","year":"2016","unstructured":"Minami T, Satoh K, Nogi M, Kudo S, Miyata S, Tanaka S-i, et al. Statins up-regulate SmgGDS through \u03b21-integrin\/Akt1 pathway in endothelial cells. Cardiovasc Resarch. 2016;109(1):151\u201361.","journal-title":"Cardiovasc Resarch."},{"issue":"4","key":"9653_CR85","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s13410-018-0646-x","volume":"38","author":"G Ge","year":"2018","unstructured":"Ge G, Hou Y. Statins protect diabetic myocardial microvascular endothelial cells from injury. International Journal of Diabetes in Developing Countries. 2018;38(4):424\u201336.","journal-title":"International Journal of Diabetes in Developing Countries"},{"issue":"1","key":"9653_CR86","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3892\/mmr.2017.6616","volume":"16","author":"S Li","year":"2017","unstructured":"Li S, Cao C, Chen H, Song J, Lee C, Zhang J, et al. Atheroprotective effects of statins in patients with unstable angina by regulating the blood-borne microRNA network. Mol Med Rep. 2017;16(1):817\u201327.","journal-title":"Mol Med Rep"},{"issue":"6","key":"9653_CR87","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/infdis\/jiaa196","volume":"222","author":"C de Filippi","year":"2020","unstructured":"deFilippi C, Toribio M, Wong LP, Sadreyev R, Grundberg I, Fitch KV, et al. Differential plasma protein regulation and statin effects in Human Immunodeficiency Virus (HIV)-infected and non-HIV-infected patients utilizing a proteomics approach. J Infect Dis. 2020;222(6):929\u201339.","journal-title":"J Infect Dis"},{"key":"9653_CR88","doi-asserted-by":"crossref","unstructured":"Alexander RW. Inflammation and coronary artery disease.\u00a0N Engl J Med. 1994;331(7):468\u20139.","DOI":"10.1056\/NEJM199408183310709"},{"issue":"2","key":"9653_CR89","first-page":"189","volume":"24","author":"T Walter","year":"2010","unstructured":"Walter T, Suselbeck T, Borggrefe M, Swoboda S, Hoffmeister HM, Dempfle C-E. Effect of atorvastatin on cellular adhesion molecules on leukocytes in patients with normocholesterolemic coronary artery disease. In Vivo. 2010;24(2):189\u201393.","journal-title":"In Vivo"},{"issue":"4","key":"9653_CR90","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/cvr\/cvu171","volume":"103","author":"JL Johnson","year":"2014","unstructured":"Johnson JL. Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis. Cardiovasc Res. 2014;103(4):452\u201360.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"9653_CR91","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1159\/000443123","volume":"38","author":"DA Chistiakov","year":"2016","unstructured":"Chistiakov DA, Orekhov AN, Bobryshev YV. LOX-1-mediated effects on vascular cells in atherosclerosis. Cell Physiol Biochem. 2016;38(5):1851\u20139.","journal-title":"Cell Physiol Biochem"},{"issue":"8","key":"9653_CR92","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1113\/JP279528","volume":"598","author":"HJ Sanyour","year":"2020","unstructured":"Sanyour HJ, Li N, Rickel AP, Torres HM, Anderson RH, Miles MR, et al. Statin-mediated cholesterol depletion exerts coordinated effects on the alterations in rat vascular smooth muscle cell biomechanics and migration. J Physiol. 2020;598(8):1505\u201322.","journal-title":"J Physiol"},{"issue":"1","key":"9653_CR93","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11010-005-3086-0","volume":"269","author":"S Nishida","year":"2005","unstructured":"Nishida S, Matsuoka H, Tsubaki M, Tanimori Y, Yanae M, Fujii Y, et al. Mevastatin induces apoptosis in HL60 cells dependently on decrease in phosphorylated ERK. Mol Cell Biochem. 2005;269(1):109\u201314.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"9653_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-9966-29-127","volume":"29","author":"Y Kidera","year":"2010","unstructured":"Kidera Y, Tsubaki M, Yamazoe Y, Shoji K, Nakamura H, Ogaki M, et al. Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho\/Rho-associated coiled-coil-containing protein kinase pathway. J Exp Clin Cancer Res. 2010;29(1):1\u201311.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"9653_CR95","first-page":"3186","volume":"5","author":"M Tsubaki","year":"2015","unstructured":"Tsubaki M, Takeda T, Kino T, Obata N, Itoh T, Imano M, et al. Statins improve survival by inhibiting spontaneous metastasis and tumor growth in a mouse melanoma model. Am J Cancer Res. 2015;5(10):3186.","journal-title":"Am J Cancer Res"},{"issue":"3","key":"9653_CR96","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3892\/ijo.2010.892","volume":"38","author":"B Relja","year":"2011","unstructured":"Relja B, Meder F, Wang M, Blaheta R, Henrich D, Marzi I, et al. Simvastatin modulates the adhesion and growth of hepatocellular carcinoma cells via decrease of integrin expression and ROCK. Int J Oncol. 2011;38(3):879\u201385.","journal-title":"Int J Oncol"},{"key":"9653_CR97","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fonc.2017.00040","volume":"7","author":"A Morandi","year":"2017","unstructured":"Morandi A, Taddei ML, Chiarugi P, Giannoni E. Targeting the metabolic reprogramming that controls epithelial-to-mesenchymal transition in aggressive tumors. Front Oncol. 2017;7:40.","journal-title":"Front Oncol"},{"issue":"3","key":"9653_CR98","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4143\/crt.2012.44.3.151","volume":"44","author":"F Nurwidya","year":"2012","unstructured":"Nurwidya F, Takahashi F, Murakami A, Takahashi K. Epithelial mesenchymal transition in drug resistance and metastasis of lung cancer. Cancer research and treatment: official journal of Korean Cancer Association. 2012;44(3):151.","journal-title":"Cancer research and treatment: official journal of Korean Cancer Association"},{"issue":"1","key":"9653_CR99","doi-asserted-by":"publisher","first-page":"265","DOI":"10.7150\/thno.27246","volume":"9","author":"H Jin","year":"2019","unstructured":"Jin H, He Y, Zhao P, Hu Y, Tao J, Chen J, et al. Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin \u03b23\/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery. Theranostics. 2019;9(1):265.","journal-title":"Theranostics"},{"issue":"1","key":"9653_CR100","doi-asserted-by":"publisher","first-page":"362","DOI":"10.18632\/oncotarget.6238","volume":"7","author":"S-H Yang","year":"2016","unstructured":"Yang S-H, Lin H-Y, Changou CA, Chen C-H, Liu Y-R, Wang J, et al. Integrin \u03b23 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma. Oncotarget. 2016;7(1):362.","journal-title":"Oncotarget"},{"issue":"9","key":"9653_CR101","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.3324\/haematol.2019.236000","volume":"105","author":"J Delgado","year":"2020","unstructured":"Delgado J, Nadeu F, Colomer D, Campo E. Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies. Haematologica. 2020;105(9):2205.","journal-title":"Haematologica"},{"key":"9653_CR102","doi-asserted-by":"crossref","unstructured":"Burger JA, Gribben JG, editors. The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies. Seminars in cancer biology; 2014: Elsevier.","DOI":"10.1016\/j.semcancer.2013.08.011"},{"issue":"1","key":"9653_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-78315-0","volume":"10","author":"N Gimenez","year":"2020","unstructured":"Gimenez N, Tripathi R, Gir\u00f3 A, Rosich L, L\u00f3pez-Guerra M, L\u00f3pez-Oreja I, et al. Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemia. Sci Rep. 2020;10(1):1\u201316.","journal-title":"Sci Rep"},{"issue":"10","key":"9653_CR104","doi-asserted-by":"publisher","first-page":"17975","DOI":"10.1002\/jcp.28430","volume":"234","author":"M Tsubaki","year":"2019","unstructured":"Tsubaki M, Takeda T, Obata N, Kawashima K, Tabata M, Imano M, et al. Combination therapy with dacarbazine and statins improved the survival rate in mice with metastatic melanoma. J Cell Physiol. 2019;234(10):17975\u201389.","journal-title":"J Cell Physiol"},{"issue":"3","key":"9653_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20030506","volume":"20","author":"P-L Shao","year":"2019","unstructured":"Shao P-L, Wu S-C, Lin Z-Y, Ho M-L, Chen C-H, Wang C-Z. Alpha-5 integrin mediates simvastatin-induced osteogenesis of bone marrow mesenchymal stem cells. Int J Mol Sci. 2019;20(3): 506.","journal-title":"Int J Mol Sci"},{"key":"9653_CR106","doi-asserted-by":"crossref","unstructured":"Kappelmayer J, Nagy B. The interaction of selectins and PSGL-1 as a key component in thrombus formation and cancer progression. BioMed Res Int. 2017;2017:6138145.","DOI":"10.1155\/2017\/6138145"},{"key":"9653_CR107","doi-asserted-by":"crossref","unstructured":"Kansas GS. Selectins and their ligands: current concepts and controversies. Blood. 1996;88(9):3259-87.","DOI":"10.1182\/blood.V88.9.3259.bloodjournal8893259"},{"issue":"3","key":"9653_CR108","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1023\/A:1006626500852","volume":"17","author":"T Krause","year":"1999","unstructured":"Krause T, Turner G. Are selectins involved in metastasis? Clin Exp Metas. 1999;17(3):183\u201392.","journal-title":"Clin Exp Metas"},{"issue":"9","key":"9653_CR109","first-page":"5820","volume":"14","author":"U Schindler","year":"1994","unstructured":"Schindler U, Baichwal VR. Three NF-kappa B binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression. Mol Cell Biol. 1994;14(9):5820\u201331.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"9653_CR110","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1124\/mol.58.6.1389","volume":"58","author":"R Gnad","year":"2000","unstructured":"Gnad R, Aktories K, Kaina B, Fritz G. Inhibition of protein isoprenylation impairs Rho-regulated early cellular response to genotoxic stress. Mol Pharmacol. 2000;58(6):1389\u201397.","journal-title":"Mol Pharmacol"},{"issue":"1","key":"9653_CR111","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1096\/fj.03-0261fje","volume":"18","author":"T N\u00fcbel","year":"2004","unstructured":"N\u00fcbel T, Dippold W, Kleinert H, Kaina B, Fritz G. Lovastatin inhibits Rho-regulated expression of E-selectin by TNF-\u03b1 and attenuates tumor cell adhesion. FASEB J. 2004;18(1):140\u20132.","journal-title":"FASEB J"},{"issue":"5","key":"9653_CR112","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.thromres.2014.09.001","volume":"134","author":"F L\u00f6tsch","year":"2014","unstructured":"L\u00f6tsch F, K\u00f6nigsbr\u00fcgge O, Posch F, Zielinski C, Pabinger I, Ay C. Statins are associated with low risk of venous thromboembolism in patients with cancer: a prospective and observational cohort study. Thromb Res. 2014;134(5):1008\u201313.","journal-title":"Thromb Res"},{"issue":"17\u201318","key":"9653_CR113","first-page":"766","volume":"114","author":"K Janata","year":"2002","unstructured":"Janata K, Holzer M, Domanovits H, M\u00fcLLNER M, Bankier A, Kurtaran A, et al. Mortality of patients with pulmonary embolism. Wien Klin Wochenschr. 2002;114(17\u201318):766\u201372.","journal-title":"Wien Klin Wochenschr"},{"issue":"4","key":"9653_CR114","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11239-009-0309-3","volume":"28","author":"AA Ashrani","year":"2009","unstructured":"Ashrani AA, Heit JA. Incidence and cost burden of post-thrombotic syndrome. J Thromb Thrombolysis. 2009;28(4):465\u201376.","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"9653_CR115","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/ATVBAHA.108.162289","volume":"28","author":"TW Wakefield","year":"2008","unstructured":"Wakefield TW, Myers DD, Henke PK. Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol. 2008;28(3):387\u201391.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"9653_CR116","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/096721099700500103","volume":"5","author":"T Wakefield","year":"1997","unstructured":"Wakefield T, Strieter R, Prince M, Downing L, Greenfield L. Pathogenesis of venous thrombosis: a new insight. Cardiovasc Surg. 1997;5(1):6\u201315.","journal-title":"Cardiovasc Surg"},{"issue":"6","key":"9653_CR117","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/jim-2017-000442","volume":"65","author":"Y Feng","year":"2017","unstructured":"Feng Y, Lei B, Zhang F, Niu L, Zhang H, Zhang M. Anti-inflammatory effects of simvastatin during the resolution phase of experimentally formed venous thrombi. J Investig Med. 2017;65(6):999\u20131007.","journal-title":"J Investig Med"},{"issue":"2","key":"9653_CR118","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/01.CIR.101.2.207","volume":"101","author":"DJ Maron","year":"2000","unstructured":"Maron DJ, Fazio S, Linton MF. Current perspectives on statins. Circulation. 2000;101(2):207\u201313.","journal-title":"Circulation"},{"issue":"1","key":"9653_CR119","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0167-5273(01)00576-9","volume":"82","author":"C Bickel","year":"2002","unstructured":"Bickel C, Rupprecht HJ, Blankenberg S, Espinola-Klein C, Rippin G, Hafner G, et al. Influence of HMG\u2013CoA reductase inhibitors on markers of coagulation, systemic inflammation and soluble cell adhesion. Int J Cardiol. 2002;82(1):25\u201331.","journal-title":"Int J Cardiol"},{"issue":"2","key":"9653_CR120","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijcard.2005.01.042","volume":"106","author":"P Marschang","year":"2006","unstructured":"Marschang P, Friedrich GJ, Ditlbacher H, Stoeger A, Zur Nedden D, Kirchmair R, et al. Reduction of soluble P-selectin by statins is inversely correlated with the progression of coronary artery disease. Int J Cardiol. 2006;106(2):183\u201390.","journal-title":"Int J Cardiol"},{"issue":"4","key":"9653_CR121","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00380-008-1038-9","volume":"23","author":"H Oka","year":"2008","unstructured":"Oka H, Ikeda S, Koga S, Miyahara Y, Kohno S. Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases. Heart Vessels. 2008;23(4):249\u201356.","journal-title":"Heart Vessels"},{"issue":"1","key":"9653_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-019-1053-0","volume":"18","author":"K An","year":"2019","unstructured":"An K, Huang R, Tian S, Guo D, Wang J, Lin H, et al. Statins significantly reduce mortality in patients receiving clopidogrel without affecting platelet activation and aggregation: a systematic review and meta-analysis. Lipids Health Dis. 2019;18(1):1\u201311.","journal-title":"Lipids Health Dis"},{"issue":"5","key":"9653_CR123","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1378\/chest.123.5.1355","volume":"123","author":"R Kalawski","year":"2003","unstructured":"Kalawski R, Majewski M, Kaszkowiak E, Wysocki H, Siminiak T. Transcardiac release of soluble adhesion molecules during coronary artery bypass grafting: effects of crystalloid and blood cardioplegia. Chest. 2003;123(5):1355\u201360.","journal-title":"Chest"},{"issue":"02","key":"9653_CR124","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1055\/s-2008-1039107","volume":"57","author":"O Berkan","year":"2009","unstructured":"Berkan O, Katrancioglu N, Ozker E, Ozerdem G, Bakici Z, Yilmaz M. Reduced P-selectin in hearts pretreated with fluvastatin: a novel benefit for patients undergoing open heart surgery. Thorac Cardiovasc Surg. 2009;57(02):91\u20135.","journal-title":"Thorac Cardiovasc Surg"},{"issue":"8","key":"9653_CR125","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/j.jacc.2006.06.061","volume":"48","author":"G Patti","year":"2006","unstructured":"Patti G, Chello M, Pasceri V, Colonna D, Nusca A, Miglionico M, et al. Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy. J Am Coll Cardiol. 2006;48(8):1560\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"9653_CR126","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2459\/JCM.0b013e32833b929c","volume":"11","author":"G Patti","year":"2010","unstructured":"Patti G, Chello M, Gatto L, Alfano G, Miglionico M, Covino E, et al. Short-term atorvastatin preload reduces levels of adhesion molecules in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Results from the ARMYDA-ACS CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy. Journal of Cardiovascular Medicine. 2010;11(11):795\u2013800.","journal-title":"Journal of Cardiovascular Medicine."},{"issue":"5","key":"9653_CR127","first-page":"354","volume":"6","author":"I Altun","year":"2014","unstructured":"Altun I, Oz F, Arkaya SC, Altun I, Bilge AK, Umman B, et al. Effect of statins on endothelial function in patients with acute coronary syndrome: a prospective study using adhesion molecules and flow-mediated dilatation. Journal of clinical medicine research. 2014;6(5):354.","journal-title":"Journal of clinical medicine research"},{"issue":"24","key":"9653_CR128","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","volume":"58","author":"GN Levine","year":"2011","unstructured":"Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58(24):e44\u2013122.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"9653_CR129","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.thromres.2013.02.020","volume":"131","author":"D Kling","year":"2013","unstructured":"Kling D, Stucki C, Kronenberg S, Tuerck D, Rh\u00e9aume E, Tardif J-C, et al. Pharmacological control of platelet-leukocyte interactions by the human anti-P-selectin antibody inclacumab\u2013preclinical and clinical studies. Thromb Res. 2013;131(5):401\u201310.","journal-title":"Thromb Res"},{"issue":"2","key":"9653_CR130","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s11239-014-1142-x","volume":"39","author":"TR Sexton","year":"2015","unstructured":"Sexton TR, Wallace EL, Macaulay TE, Charnigo RJ, Evangelista V, Campbell CL, et al. The effect of rosuvastatin on thromboinflammation in the setting of acute coronary syndrome. J Thromb Thrombolysis. 2015;39(2):186\u201395.","journal-title":"J Thromb Thrombolysis"},{"issue":"9","key":"9653_CR131","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1161\/STROKEAHA.111.613182","volume":"42","author":"X Ren","year":"2011","unstructured":"Ren X, Akiyoshi K, Vandenbark AA, Hurn PD, Offner H. Programmed death-1 pathway limits central nervous system inflammation and neurologic deficits in murine experimental stroke. Stroke. 2011;42(9):2578\u201383.","journal-title":"Stroke"},{"issue":"4","key":"9653_CR132","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1161\/STROKEAHA.110.598359","volume":"42","author":"T Miyazaki","year":"2011","unstructured":"Miyazaki T, Kimura Y, Ohata H, Hashimoto T, Shibata K, Hasumi K, et al. Distinct effects of tissue-type plasminogen activator and SMTP-7 on cerebrovascular inflammation following thrombolytic reperfusion. Stroke. 2011;42(4):1097\u2013104.","journal-title":"Stroke"},{"key":"9653_CR133","doi-asserted-by":"crossref","unstructured":"deVeber G. Arterial ischemic strokes in infants and children: an overview of current approaches.\u00a0Semin Thromb Hemost. 2003;29(6):567\u201373.","DOI":"10.1055\/s-2004-815624"},{"issue":"2","key":"9653_CR134","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/ana.10423","volume":"53","author":"V Ganesan","year":"2003","unstructured":"Ganesan V, Prengler M, McShane MA, Wade AM, Kirkham FJ. Investigation of risk factors in children with arterial ischemic stroke. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society. 2003;53(2):167\u201373.","journal-title":"Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society"},{"issue":"3","key":"9653_CR135","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4103\/1673-5374.128220","volume":"9","author":"Q Tu","year":"2014","unstructured":"Tu Q, Cao H, Zhong W, Ding B, Tang X. Atorvastatin protects against cerebral ischemia\/reperfusion injury through anti-inflammatory and antioxidant effects. Neural Regen Res. 2014;9(3):268.","journal-title":"Neural Regen Res"},{"issue":"5","key":"9653_CR136","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.annemergmed.2008.07.050","volume":"53","author":"IP Aisiku","year":"2009","unstructured":"Aisiku IP, Smith WR, McClish DK, Levenson JL, Penberthy LT, Roseff SD, et al. Comparisons of high versus low emergency department utilizers in sickle cell disease. Ann Emerg Med. 2009;53(5):587\u201393.","journal-title":"Ann Emerg Med"},{"issue":"1","key":"9653_CR137","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.trsl.2015.07.001","volume":"167","author":"A Owusu-Ansah","year":"2016","unstructured":"Owusu-Ansah A, Ihunnah CA, Walker AL, Ofori-Acquah SF. Inflammatory targets of therapy in sickle cell disease. Transl Res. 2016;167(1):281\u201397.","journal-title":"Transl Res"},{"issue":"4","key":"9653_CR138","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/bjh.14580","volume":"177","author":"C Hoppe","year":"2017","unstructured":"Hoppe C, Jacob E, Styles L, Kuypers F, Larkin S, Vichinsky E. Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial. Br J Haematol. 2017;177(4):620\u20139.","journal-title":"Br J Haematol"},{"issue":"1","key":"9653_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13613-017-0349-3","volume":"8","author":"MA Wiewel","year":"2018","unstructured":"Wiewel MA, Scicluna BP, van Vught LA, Hoogendijk AJ, Zwinderman AH, Lutter R, et al. The host response in critically ill sepsis patients on statin therapy: a prospective observational study. Ann Intensive Care. 2018;8(1):1\u201312.","journal-title":"Ann Intensive Care"},{"issue":"6","key":"9653_CR140","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1161\/01.CIR.89.6.2590","volume":"89","author":"M de Lorgeril","year":"1994","unstructured":"de Lorgeril M, Boissonnat P, Mamelle N, Martin J-L, Monjaud I, Guidollet J, et al. Platelet aggregation and HDL cholesterol are predictive of acute coronary events in heart transplant recipients. Circulation. 1994;89(6):2590\u20134.","journal-title":"Circulation"},{"issue":"1","key":"9653_CR141","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/00005344-199801000-00006","volume":"31","author":"M Aviram","year":"1998","unstructured":"Aviram M, Hussein O, Rosenblat M, Schlezinger S, Hayek T, Keidar S. Interactions of platelets, macrophages, and lipoproteins in hypercholesterolemia: antiatherogenic effects of HMG-CoA reductase inhibitor therapy. J Cardiovasc Pharmacol. 1998;31(1):39\u201345.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"9653_CR142","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1042\/bj2420559","volume":"242","author":"H Andrews","year":"1987","unstructured":"Andrews H, Aitken J, Hassall D, Skinner V, Bruckdorfer K. Intracellular mechanisms in the activation of human platelets by low-density lipoproteins. Biochemical Journal. 1987;242(2):559\u201364.","journal-title":"Biochemical Journal"},{"issue":"4","key":"9653_CR143","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.thromres.2004.08.016","volume":"115","author":"M Labi\u00f3s","year":"2005","unstructured":"Labi\u00f3s M, Mart\u00ednez M, Gabriel F, Guiral V, Mart\u00ednez E, Aznar J. Effect of atorvastatin upon platelet activation in hypercholesterolemia, evaluated by flow cymetry. Thromb Res. 2005;115(4):263\u201370.","journal-title":"Thromb Res"},{"key":"9653_CR144","doi-asserted-by":"crossref","unstructured":"Barale C, Frascaroli C, Senkeev R, Cavalot F, Russo I. Simvastatin effects on inflammation and platelet activation markers in hypercholesterolemia. Biomed Res Int. 2018;2018(1):6508709.","DOI":"10.1155\/2018\/6508709"},{"issue":"1","key":"9653_CR145","doi-asserted-by":"publisher","first-page":"115","DOI":"10.5114\/aoms.2015.49216","volume":"11","author":"M Pawelczyk","year":"2015","unstructured":"Pawelczyk M, Chmielewski H, Kaczorowska B, Przyby\u0142a M, Baj Z. The influence of statin therapy on platelet activity markers in hyperlipidemic patients after ischemic stroke. Archives of medical science: AMS. 2015;11(1):115.","journal-title":"Archives of medical science: AMS"},{"issue":"5","key":"9653_CR146","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1177\/0300060518762681","volume":"46","author":"PJ Kotyla","year":"2018","unstructured":"Kotyla PJ. Short course of simvastatin has no effect on markers of endothelial activation in normolipidemic patients with systemic sclerosis. J Int Med Res. 2018;46(5):1893\u2013901.","journal-title":"J Int Med Res"},{"issue":"6","key":"9653_CR147","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1111\/j.1538-7836.2005.01403.x","volume":"3","author":"DW Sommeijer","year":"2005","unstructured":"Sommeijer DW, Joop K, Leyte A, Reitsma P, Cate HT. Pravastatin reduces fibrinogen receptor gpIIIa on platelet-derived microparticles in patients with type 2 diabetes. J Thromb Haemost. 2005;3(6):1168\u201371.","journal-title":"J Thromb Haemost"},{"issue":"1\u20132","key":"9653_CR148","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cca.2007.12.013","volume":"390","author":"W-J Lee","year":"2008","unstructured":"Lee W-J, Lee W-L, Tang Y-J, Liang K-W, Chien Y-H, Tsou SS, et al. Early Improvements in insulin sensitivity and inflammatory markers are induced by pravastatin in nondiabetic subjects with hypercholesterolemia. Clin Chim Acta. 2008;390(1\u20132):49\u201355.","journal-title":"Clin Chim Acta"},{"issue":"08","key":"9653_CR149","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1160\/TH10-12-0810","volume":"106","author":"F Mobarrez","year":"2011","unstructured":"Mobarrez F, He S, Br\u00f6ijersen A, Wiklund B, Antovic A, Antovic J, et al. Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease. Thromb Haemost. 2011;106(08):344\u201352.","journal-title":"Thromb Haemost"},{"issue":"08","key":"9653_CR150","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1160\/TH13-03-0238","volume":"110","author":"R Suades","year":"2013","unstructured":"Suades R, Padr\u00f3 T, Alonso R, Mata P, Badimon L. Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells. Thromb Haemost. 2013;110(08):366\u201377.","journal-title":"Thromb Haemost"},{"key":"9653_CR151","doi-asserted-by":"crossref","unstructured":"Wai Wong C, Dye DE, Coombe DR. The role of immunoglobulin superfamily cell adhesion molecules in cancer metastasis. Int J Cell Biol. 2012;2012(1):340296.","DOI":"10.1155\/2012\/340296"},{"issue":"5","key":"9653_CR152","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ceb.2007.09.010","volume":"19","author":"AR Aricescu","year":"2007","unstructured":"Aricescu AR, Jones EY. Immunoglobulin superfamily cell adhesion molecules: zippers and signals. Curr Opin Cell Biol. 2007;19(5):543\u201350.","journal-title":"Curr Opin Cell Biol"},{"issue":"3","key":"9653_CR153","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrm3068","volume":"12","author":"U Cavallaro","year":"2011","unstructured":"Cavallaro U, Dejana E. Adhesion molecule signalling: not always a sticky business. Nat Rev Mol Cell Biol. 2011;12(3):189\u201397.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"9653_CR154","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0021-9150(97)00118-4","volume":"133","author":"M Sakai","year":"1997","unstructured":"Sakai M, Kobori S, Matsumura T, Biwa T, Sato Y, Takemura T, et al. HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein. Atherosclerosis. 1997;133(1):51\u20139.","journal-title":"Atherosclerosis"},{"issue":"5","key":"9653_CR155","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1159\/000025676","volume":"36","author":"DR Manka","year":"1999","unstructured":"Manka DR, Wiegman P, Din S, Sanders JM, Green SA, Gimple LW, et al. Arterial injury increases expression of inflammatory adhesion molecules in the carotid arteries of Apolipoprotein-E-deficient Mice1. J Vasc Res. 1999;36(5):372\u20138.","journal-title":"J Vasc Res"},{"issue":"3","key":"9653_CR156","first-page":"209","volume":"4","author":"H Seeger","year":"2001","unstructured":"Seeger H, Wallwiener D, Mueck A. Lipid-independent effects of an estrogen\u2013statin combination: inhibition of expression of adhesion molecules and plasminogen activator inhibitor-1 in human endothelial cell cultures. Climacteric. 2001;4(3):209\u201314.","journal-title":"Climacteric"},{"issue":"11","key":"9653_CR157","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.lfs.2004.03.005","volume":"75","author":"D Zapolska-Downar","year":"2004","unstructured":"Zapolska-Downar D, Siennicka A, Kaczmarczyk M, Ko\u0142odziej B, Naruszewicz M. Simvastatin modulates TNF\u03b1-induced adhesion molecules expression in human endothelial cells. Life Sci. 2004;75(11):1287\u2013302.","journal-title":"Life Sci"},{"issue":"5","key":"9653_CR158","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1681\/ASN.2015040460","volume":"27","author":"T Yoshida","year":"2016","unstructured":"Yoshida T, Yamashita M, Iwai M, Hayashi M. Endothelial Kr\u00fcppel-like factor 4 mediates the protective effect of statins against ischemic AKI. J Am Soc Nephrol. 2016;27(5):1379\u201388.","journal-title":"J Am Soc Nephrol"},{"key":"9653_CR159","doi-asserted-by":"crossref","unstructured":"Demir B, Onal B, Ozyazgan S, Demir E, Bakuy V, Akkan AG. The effects of pitavastatin on nuclear factor-kappa b and icam-1 in human saphenous vein graft endothelial culture. Cardiovasc Ther. 2019;2019(1):2549432.","DOI":"10.1155\/2019\/2549432"},{"issue":"1","key":"9653_CR160","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0021-9150(96)05953-9","volume":"127","author":"RH B\u00f6ger","year":"1996","unstructured":"B\u00f6ger RH, Bode-B\u00f6ger SM, Fr\u00f6lich JC. The l-arginine\u2014nitric oxide pathway: role in atherosclerosis and therapeutic implications. Atherosclerosis. 1996;127(1):1\u201311.","journal-title":"Atherosclerosis"},{"issue":"3","key":"9653_CR161","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/107602960200800310","volume":"8","author":"MA Sardo","year":"2002","unstructured":"Sardo MA, Castaldo M, Cinquegrani M, Bonaiuto M, Maesano A, Versace A, et al. Effects of atorvastatin treatment on sICAM-1 and plasma nitric oxide levels in hypercholesterolemic subjects. Clin Appl Thromb Hemost. 2002;8(3):257\u201363.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"3","key":"9653_CR162","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s10016-005-0011-7","volume":"19","author":"ES Xenos","year":"2005","unstructured":"Xenos ES, Stevens SL, Freeman MB, Cassada DC, Goldman MH. Nitric oxide mediates the effect of fluvastatin on intercellular adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 expression on human endothelial cells. Ann Vasc Surg. 2005;19(3):386\u201392.","journal-title":"Ann Vasc Surg"},{"issue":"7","key":"9653_CR163","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/jat.4094","volume":"41","author":"D Dymkowska","year":"2021","unstructured":"Dymkowska D, Wrzosek A, Zab\u0142ocki K. Atorvastatin and pravastatin stimulate nitric oxide and reactive oxygen species generation, affect mitochondrial network architecture and elevate nicotinamide N-methyltransferase level in endothelial cells. J Appl Toxicol. 2021;41(7):1076\u201388.","journal-title":"J Appl Toxicol"},{"issue":"3","key":"9653_CR164","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1253\/circj.CJ-08-1102","volume":"73","author":"Y Higashi","year":"2009","unstructured":"Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J. 2009;73(3):411\u20138.","journal-title":"Circ J"},{"issue":"2","key":"9653_CR165","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1748-1716.2009.01964.x","volume":"196","author":"PM Vanhoutte","year":"2009","unstructured":"Vanhoutte PM, Shimokawa H, Tang EH, Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol. 2009;196(2):193\u2013222.","journal-title":"Acta Physiol"},{"issue":"6","key":"9653_CR166","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s10067-015-2912-3","volume":"34","author":"N Garg","year":"2015","unstructured":"Garg N, Krishan P, Syngle A. Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis. Clin Rheumatol. 2015;34(6):1065\u201371.","journal-title":"Clin Rheumatol"},{"key":"9653_CR167","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.preghy.2020.03.004","volume":"20","author":"N de Alwis","year":"2020","unstructured":"de Alwis N, Beard S, Mangwiro YT, Binder NK, Tu\u2019uhevaha J, Brownfoot FC, et al. Pravastatin as the statin of choice for reducing pre-eclampsia-associated endothelial dysfunction. Pregnancy hypertension. 2020;20:83\u201391.","journal-title":"Pregnancy hypertension"},{"issue":"30","key":"9653_CR168","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1093\/eurheartj\/ehz393","volume":"40","author":"MS Leisegang","year":"2019","unstructured":"Leisegang MS, Bibli S-I, G\u00fcnther S, Pfl\u00fcger-M\u00fcller B, Oo JA, H\u00f6per C, et al. Pleiotropic effects of laminar flow and statins depend on the Kr\u00fcppel-like factor-induced lncRNA MANTIS. Eur Heart J. 2019;40(30):2523\u201333.","journal-title":"Eur Heart J"},{"key":"9653_CR169","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.mvr.2017.02.002","volume":"112","author":"F Imanparast","year":"2017","unstructured":"Imanparast F, Faramarzi MA, Vatannejad A, Paknejad M, Deiham B, Kobarfard F, et al. mZD7349 peptide-conjugated PLGA nanoparticles directed against VCAM-1 for targeted delivery of simvastatin to restore dysfunctional HUVECs. Microvasc Res. 2017;112:14\u20139.","journal-title":"Microvasc Res"},{"issue":"6","key":"9653_CR170","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S1568-9972(03)00049-1","volume":"2","author":"BR Kwak","year":"2003","unstructured":"Kwak BR, Mulhaupt F, Mach F. Atherosclerosis: anti-inflammatory and immunomodulatory activities of statins. Autoimmun Rev. 2003;2(6):332\u20138.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"9653_CR171","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/rheumatology\/ken466","volume":"48","author":"F Montecucco","year":"2009","unstructured":"Montecucco F, Burger F, Pelli G, Poku NK, Berlier C, Steffens S, et al. Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes. Rheumatology. 2009;48(3):233\u201342.","journal-title":"Rheumatology"},{"issue":"6","key":"9653_CR172","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/j.ajpath.2012.08.023","volume":"181","author":"J Asai","year":"2012","unstructured":"Asai J, Takenaka H, Hirakawa S, Sakabe J-i, Hagura A, Kishimoto S, et al. Topical simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and lymphangiogenesis. The American journal of pathology. 2012;181(6):2217\u201324.","journal-title":"The American journal of pathology."},{"issue":"6","key":"9653_CR173","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1177\/1933719111430998","volume":"19","author":"H Cakmak","year":"2012","unstructured":"Cakmak H, Basar M, Seval-Celik Y, Osteen KG, Duleba AJ, Taylor HS, et al. Statins inhibit monocyte chemotactic protein 1 expression in endometriosis. Reprod Sci. 2012;19(6):572\u20139.","journal-title":"Reprod Sci"},{"issue":"4","key":"9653_CR174","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s11373-008-9243-1","volume":"15","author":"Z Hu","year":"2008","unstructured":"Hu Z, Zhang F, Yang Z, Yang N, Zhang D, Zhang J, et al. Combination of simvastatin administration and EPC transplantation enhances angiogenesis and protects against apoptosis for hindlimb ischemia. J Biomed Sci. 2008;15(4):509\u201317.","journal-title":"J Biomed Sci"},{"issue":"6","key":"9653_CR175","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1161\/01.RES.0000014081.30867.F8","volume":"90","author":"C Urbich","year":"2002","unstructured":"Urbich C, Dernbach E, Zeiher AM, Dimmeler S. Double-edged role of statins in angiogenesis signaling. Circ Res. 2002;90(6):737\u201344.","journal-title":"Circ Res"},{"key":"9653_CR176","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ejphar.2014.06.041","volume":"740","author":"M Dworacka","year":"2014","unstructured":"Dworacka M, Krzy\u017cag\u00f3rska E, Weso\u0142owska A, Zharmakhanova G, Iskakova S, Dworacki G. Circulating monocyte chemotactic protein 1 (MCP-1), vascular cell adhesion molecule 1 (VCAM-1) and angiogenin in type 2 diabetic patients treated with statins in low doses. Eur J Pharmacol. 2014;740:474\u20139.","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"9653_CR177","doi-asserted-by":"publisher","DOI":"10.1111\/1755-5922.12307","volume":"35","author":"ES Guimar\u00e3es","year":"2017","unstructured":"Guimar\u00e3es ES, Cerda A, Dorea EL, Bernik MMS, Gusukuma MC, Pinto GA, et al. Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients. Cardiovasc Ther. 2017;35(6): e12307.","journal-title":"Cardiovasc Ther"},{"issue":"9","key":"9653_CR178","doi-asserted-by":"publisher","first-page":"e0256996","DOI":"10.1371\/journal.pone.0256996","volume":"16","author":"M Niedzielski","year":"2021","unstructured":"Niedzielski M, Broncel M, Gorzelak-Pabi\u015b P, Wo\u017aniak E. A comparison of the effects of monotherapy with rosuvastatin, atorvastatin or ezetimibe versus combination treatment with rosuvastatin-ezetimibe and atorvastatin-ezetimibe on the integrity of vascular endothelial cells damaged by oxidized cholesterol. PLoS ONE. 2021;16(9): e0256996.","journal-title":"PLoS ONE"},{"key":"9653_CR179","doi-asserted-by":"crossref","unstructured":"Sun C, Zheng W, Liang L, Liu Z, Sun W, Tang R. Ezetimibe improves rosuvastatin effects on inflammation and vascular endothelial function in acute coronary syndrome patients undergoing PCI. J Interv Cardiol. 2021;2021(1):2995602.","DOI":"10.1155\/2021\/2995602"},{"issue":"1","key":"9653_CR180","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/00015385.2017.1321908","volume":"73","author":"MH Kim","year":"2018","unstructured":"Kim MH, Kim C-E, Kim S-W. Rosuvastatin inhibits high glucose-stimulated upregulation of VCAM-1 via the MAPK-signalling pathway in endothelial cells. Acta Cardiol. 2018;73(1):13\u20138.","journal-title":"Acta Cardiol"},{"issue":"2","key":"9653_CR181","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.bbrc.2017.08.023","volume":"495","author":"J Park","year":"2018","unstructured":"Park J, Hwang I, Kim S-J, Youn S-W, Hur J, Kim H-S. Atorvastatin prevents endothelial dysfunction in high glucose condition through Skp2-mediated degradation of FOXO1 and ICAM-1. Biochem Biophys Res Commun. 2018;495(2):2050\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"9653_CR182","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1751-7141.2009.00054.x","volume":"13","author":"JE Mason","year":"2010","unstructured":"Mason JE, Starke RD, Van Kirk JE. Gamma-Glutamyl transferase: a novel cardiovascular risk BioMarker. Prev Cardiol. 2010;13(1):36\u201341.","journal-title":"Prev Cardiol"},{"issue":"6","key":"9653_CR183","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/10715760410001694026","volume":"38","author":"D-H Lee","year":"2004","unstructured":"Lee D-H, Blomhoff R, Jacobs DR. Review is serum gamma glutamyltransferase a marker of oxidative stress? Free Radical Res. 2004;38(6):535\u20139.","journal-title":"Free Radical Res"},{"issue":"11","key":"9653_CR184","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1161\/01.CIR.0000120558.41356.E6","volume":"109","author":"A Paolicchi","year":"2004","unstructured":"Paolicchi A, Emdin M, Ghliozeni E, Ciancia E, Passino C, Popoff G, et al. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation. 2004;109(11):1440.","journal-title":"Circulation"},{"issue":"1","key":"9653_CR185","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2261-14-145","volume":"14","author":"G Li","year":"2014","unstructured":"Li G, Wu X-w, Lu W-h, Ai R, Chen F, Tang Z-z. Effect of atorvastatin on the expression of gamma-glutamyl transferase in aortic atherosclerotic plaques of apolipoprotein E\u2013knockout mice. BMC cardiovascular disorders. 2014;14(1):1\u20136.","journal-title":"BMC cardiovascular disorders."},{"issue":"1","key":"9653_CR186","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10571-016-0331-x","volume":"37","author":"X Pan","year":"2017","unstructured":"Pan X, Hou R, Ma A, Wang T, Wu M, Zhu X, et al. Atorvastatin upregulates the expression of miR-126 in apolipoprotein E-knockout mice with carotid atherosclerotic plaque. Cell Mol Neurobiol. 2017;37(1):29\u201336.","journal-title":"Cell Mol Neurobiol"},{"key":"9653_CR187","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/RMHP.S34587","volume":"5","author":"MA Clark","year":"2012","unstructured":"Clark MA, Duhay FG, Thompson AK, Keyes MJ, Svensson LG, Bonow RO, et al. Clinical and economic outcomes after surgical aortic valve replacement in Medicare patients. Risk management and healthcare policy. 2012;5:117.","journal-title":"Risk management and healthcare policy"},{"key":"9653_CR188","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jss.2018.04.054","volume":"230","author":"N Venardos","year":"2018","unstructured":"Venardos N, Deng X-S, Yao Q, Weyant MJ, Reece TB, Meng X, et al. Simvastatin reduces the TLR4-induced inflammatory response in human aortic valve interstitial cells. J Surg Res. 2018;230:101\u20139.","journal-title":"J Surg Res"},{"issue":"1","key":"9653_CR189","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41568-018-0081-9","volume":"19","author":"NK Altorki","year":"2019","unstructured":"Altorki NK, Markowitz GJ, Gao D, Port JL, Saxena A, Stiles B, et al. The lung microenvironment: an important regulator of tumour growth and metastasis. Nat Rev Cancer. 2019;19(1):9\u201331.","journal-title":"Nat Rev Cancer"},{"issue":"23","key":"9653_CR190","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1242\/jcs.116392","volume":"125","author":"FR Balkwill","year":"2012","unstructured":"Balkwill FR, Capasso M, Hagemann T. The tumor microenvironment at a glance. J Cell Sci. 2012;125(23):5591\u20136.","journal-title":"J Cell Sci"},{"key":"9653_CR191","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.canlet.2020.05.005","volume":"484","author":"S Galland","year":"2020","unstructured":"Galland S, Martin P, Fregni G, Letovanec I, Stamenkovic I. Attenuation of the pro-inflammatory signature of lung cancer-derived mesenchymal stromal cells by statins. Cancer Lett. 2020;484:50\u201364.","journal-title":"Cancer Lett"},{"issue":"11","key":"9653_CR192","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1002\/jcp.24381","volume":"228","author":"B AL\u2010Husein","year":"2013","unstructured":"AL\u2010Husein B, Goc A, Somanath PR. Suppression of interactions between prostate tumor cell\u2010surface integrin and endothelial ICAM\u20101 by simvastatin inhibits micrometastasis. J Cellular physiol. 2013;228(11):2139\u201348.","journal-title":"J Cellular physiol"},{"key":"9653_CR193","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fncel.2015.00175","volume":"9","author":"J Dzwonek","year":"2015","unstructured":"Dzwonek J, Wilczynski GM. CD44: molecular interactions, signaling and functions in the nervous system. Front Cell Neurosci. 2015;9:175.","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"9653_CR194","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4103\/jomfp.JOMFP_246_18","volume":"23","author":"MN Mishra","year":"2019","unstructured":"Mishra MN, Chandavarkar V, Sharma R, Bhargava D. Structure, function and role of CD44 in neoplasia. Journal of Oral and Maxillofacial Pathology: JOMFP. 2019;23(2):267.","journal-title":"Journal of Oral and Maxillofacial Pathology: JOMFP"},{"issue":"24","key":"9653_CR195","doi-asserted-by":"publisher","first-page":"7970","DOI":"10.1111\/febs.16179","volume":"289","author":"Q Guo","year":"2022","unstructured":"Guo Q, Yang C, Gao F. The state of CD44 activation in cancer progression and therapeutic targeting. FEBS J. 2022;289(24):7970\u201386.","journal-title":"FEBS J"},{"key":"9653_CR196","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-018-1066-z","volume":"20","author":"CH Beckwitt","year":"2018","unstructured":"Beckwitt CH, Brufsky A, Oltvai ZN, Wells A. Statin drugs to reduce breast cancer recurrence and mortality. Breast Cancer Res. 2018;20:1\u201311.","journal-title":"Breast Cancer Res"},{"key":"9653_CR197","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00807","volume":"9","author":"A Chimento","year":"2019","unstructured":"Chimento A, Casaburi I, Avena P, Trotta F, De Luca A, Rago V, et al. Cholesterol and its metabolites in tumor growth: therapeutic potential of statins in cancer treatment. Front Endocrinol. 2019;9: 807.","journal-title":"Front Endocrinol"},{"issue":"13","key":"9653_CR198","doi-asserted-by":"publisher","first-page":"11314","DOI":"10.1074\/jbc.M110.193714","volume":"286","author":"CC Mandal","year":"2011","unstructured":"Mandal CC, Ghosh-Choudhury N, Yoneda T, Choudhury GG, Ghosh-Choudhury N. Simvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44. J Biol Chem. 2011;286(13):11314\u201327.","journal-title":"J Biol Chem"},{"issue":"3","key":"9653_CR199","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1074\/jbc.M110.184010","volume":"286","author":"T Murai","year":"2011","unstructured":"Murai T, Maruyama Y, Mio K, Nishiyama H, Suga M, Sato C. Low cholesterol triggers membrane microdomain-dependent CD44 shedding and suppresses tumor cell migration. J Biol Chem. 2011;286(3):1999\u20132007.","journal-title":"J Biol Chem"},{"issue":"3","key":"9653_CR200","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.bbrc.2013.10.112","volume":"441","author":"S Rentala","year":"2013","unstructured":"Rentala S, Chintala R, Guda M, Chintala M, Komarraju AL, Mangamoori LN. Atorvastatin inhibited Rho-associated kinase 1 (ROCK1) and focal adhesion kinase (FAK) mediated adhesion and differentiation of CD133+ CD44+ prostate cancer stem cells. Biochem Biophys Res Commun. 2013;441(3):586\u201392.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"9653_CR201","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1002\/jcb.27544","volume":"120","author":"S Koohestanimobarhan","year":"2019","unstructured":"Koohestanimobarhan S, Salami S, Imeni V, Mohammadi Z, Bayat O. Lipophilic statins antagonistically alter the major epithelial-to-mesenchymal transition signaling pathways in breast cancer stem\u2013like cells via inhibition of the mevalonate pathway. J Cell Biochem. 2019;120(2):2515\u201331.","journal-title":"J Cell Biochem"},{"issue":"5","key":"9653_CR202","doi-asserted-by":"publisher","first-page":"367","DOI":"10.4196\/kjpp.2022.26.5.367","volume":"26","author":"YS Choi","year":"2022","unstructured":"Choi YS, Cho HJ, Jung HJ. Atorvastatin inhibits the proliferation of MKN45-derived gastric cancer stem cells in a mevalonate pathway-independent manner. The Korean Journal of Physiology & Pharmacology: Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology. 2022;26(5):367\u201375.","journal-title":"The Korean Journal of Physiology & Pharmacology: Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology"},{"key":"9653_CR203","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.canlet.2016.10.020","volume":"385","author":"K Tanaka","year":"2017","unstructured":"Tanaka K, Osada H, Murakami-Tonami Y, Horio Y, Hida T, Sekido Y. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP\/CD44 growth stimulatory axis. Cancer Lett. 2017;385:215\u201324.","journal-title":"Cancer Lett"},{"issue":"10","key":"9653_CR204","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1530\/ERC-18-0132","volume":"25","author":"S Kato","year":"2018","unstructured":"Kato S, Liberona M, Cerda-Infante J, S\u00e1nchez M, Henr\u00edquez J, Bizama C, et al. Simvastatin interferes with cancer \u2018stem-cell\u2019plasticity reducing metastasis in ovarian cancer. Endocr Relat Cancer. 2018;25(10):821\u201336.","journal-title":"Endocr Relat Cancer"},{"issue":"20","key":"9653_CR205","doi-asserted-by":"publisher","first-page":"14835","DOI":"10.1016\/S0021-9258(17)36700-5","volume":"269","author":"S Aksoy","year":"1994","unstructured":"Aksoy S, Szumlanski CL, Weinshilboum RM. Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization. Journal of Biological Chemistry. 1994;269(20):14835\u201340.","journal-title":"Journal of Biological Chemistry."},{"issue":"52","key":"9653_CR206","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.1038\/onc.2008.264","volume":"27","author":"Y Wu","year":"2008","unstructured":"Wu Y, Siadaty M, Berens M, Hampton G, Theodorescu D. Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration. Oncogene. 2008;27(52):6679\u201389.","journal-title":"Oncogene"},{"key":"9653_CR207","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.omtn.2018.03.011","volume":"11","author":"D-H Bach","year":"2018","unstructured":"Bach D-H, Kim D, Bae SY, Kim WK, Hong J-Y, Lee H-J, et al. Targeting nicotinamide N-methyltransferase and miR-449a in EGFR-TKI-resistant non-small-cell lung cancer cells. Molecular Therapy-Nucleic Acids. 2018;11:455\u201367.","journal-title":"Molecular Therapy-Nucleic Acids"},{"issue":"2","key":"9653_CR208","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1159\/000369731","volume":"35","author":"T Yu","year":"2015","unstructured":"Yu T, Wang Y-T, Chen P, Li Y-H, Chen Y-X, Zeng H, et al. Effects of nicotinamide N-methyltransferase on PANC-1 cells proliferation, metastatic potential and survival under metabolic stress. Cell Physiol Biochem. 2015;35(2):710\u201321.","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"9653_CR209","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/emm.2006.54","volume":"38","author":"B-H Lim","year":"2006","unstructured":"Lim B-H, Cho B-I, Kim YN, Kim JW, Park S-T, Lee C-W. Overexpression of nicotinamide N-methyltransferase in gastric cancer tissues and its potential post-translational modification. Exp Mol Med. 2006;38(5):455\u201365.","journal-title":"Exp Mol Med"},{"issue":"9","key":"9653_CR210","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1002\/1878-0261.12544","volume":"13","author":"J Li","year":"2019","unstructured":"Li J, You S, Zhang S, Hu Q, Wang F, Chi X, et al. Elevated N-methyltransferase expression induced by hepatic stellate cells contributes to the metastasis of hepatocellular carcinoma via regulation of the CD44v3 isoform. Mol Oncol. 2019;13(9):1993\u20132009.","journal-title":"Mol Oncol"},{"key":"9653_CR211","doi-asserted-by":"crossref","unstructured":"Abela GS, Katkoori VR, Pathak DR, Bumpers HL, Leja M, ul Abideen Z, et al. Cholesterol crystals induce mechanical trauma, inflammation, and neo-vascularization in solid cancers as in atherosclerosis. Am Heart J Plus Cardiol Res Pract, 2023;35:100317","DOI":"10.1016\/j.ahjo.2023.100317"},{"key":"9653_CR212","doi-asserted-by":"publisher","unstructured":"Mu D, Li J, Qi Y, Sun X, Liu Y, Shen S, et al.  Novel hyaluronic acid-coated polymeric micelles with ROS scavenging to encapsulate statins for alleviating atherosclerosis. 2020. https:\/\/doi.org\/10.21203\/rs.3.rs-89851\/v1.","DOI":"10.21203\/rs.3.rs-89851\/v1"},{"issue":"17","key":"9653_CR213","doi-asserted-by":"publisher","first-page":"9541","DOI":"10.1039\/D0NR00308E","volume":"12","author":"SH Nasr","year":"2020","unstructured":"Nasr SH, Rashidijahanabad Z, Ramadan S, Kauffman N, Parameswaran N, Zinn KR, et al. Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles. Nanoscale. 2020;12(17):9541\u201356.","journal-title":"Nanoscale"},{"issue":"3","key":"9653_CR214","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1161\/01.ATV.0000059384.34874.F0","volume":"23","author":"A Rezaie-Majd","year":"2003","unstructured":"Rezaie-Majd A, Prager GW, Bucek RA, Schernthaner GH, Maca T, Kress H-G, et al. Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients. Arterioscler Thromb Vasc Biol. 2003;23(3):397\u2013403.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"9653_CR215","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1046\/j.1538-7836.2003.00412.x","volume":"1","author":"Y Dimitrova","year":"2003","unstructured":"Dimitrova Y, Dunoyer-Geindre S, Reber G, Mach F, Kruithof E, De Moerloose P. Effects of statins on adhesion molecule expression in endothelial cells. J Thromb Haemost. 2003;1(11):2290\u20139.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"9653_CR216","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1182\/blood-2003-12-4218","volume":"104","author":"R Schmidmaier","year":"2004","unstructured":"Schmidmaier R, Baumann P, Simsek M, Dayyani F, Emmerich B, Meinhardt G. The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion\u2013mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinase. Blood. 2004;104(6):1825\u201332.","journal-title":"Blood"},{"issue":"4","key":"9653_CR217","first-page":"400","volume":"6","author":"MK DeGorter","year":"2013","unstructured":"DeGorter MK, Tirona RG, Schwarz UI, Choi Y-H, Dresser GK, Suskin N, et al. Clinical and pharmacogenetic predictors of circulating atorvastatin and rosuvastatin concentrations in routine clinical care. Circulation: Cardiovascular Genetics. 2013;6(4):400\u20138.","journal-title":"Circulation: Cardiovascular Genetics"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09653-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-025-09653-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09653-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:03:32Z","timestamp":1770192212000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-025-09653-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":217,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9653"],"URL":"https:\/\/doi.org\/10.1007\/s12026-025-09653-2","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"31 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable to a review article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}